611 related articles for article (PubMed ID: 3815996)
1. Technetium-99m MDP scintigraphy. An insensitive tool for the detection of bone marrow metastases.
Gulenchyn KY; Papoff W
Clin Nucl Med; 1987 Jan; 12(1):45-6. PubMed ID: 3815996
[TBL] [Abstract][Full Text] [Related]
2. [Bone marrow scintigraphy using radiocolloids in bone metastases. Sensitivity, specificity, reliability and indications].
Fritz P; Adolph J; Bubeck B; Georgi P; zum Winkel K
Rofo; 1986 Jun; 144(6):689-95. PubMed ID: 3012705
[TBL] [Abstract][Full Text] [Related]
3. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases.
Limouris GS; Voliotopoulos V; Stavraka A; Vlahos L
Anticancer Res; 1997; 17(3B):1615-8. PubMed ID: 9179204
[TBL] [Abstract][Full Text] [Related]
4. [MR tomography and bone marrow scintigraphy in the screening of skeletal metastases in patients with breast carcinoma].
Layer G; Rieker O; Dörr D; Schnakenberg D; Steudel A; Reiser M
Rofo; 1994 May; 160(5):448-52. PubMed ID: 8173054
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99m-labeled antigranulocyte antibody bone marrow scintigraphy.
Lee KH; Chung JK; Choi CW; Jeong JM; Lee DS; Bang YJ; Lee MC; Kim NK; Koh CS
J Nucl Med; 1995 Oct; 36(10):1800-5. PubMed ID: 7562046
[TBL] [Abstract][Full Text] [Related]
6. Bone scanning and radiography in the evaluation of patients with malignant lymphoma.
Jánoskuti L; Szilvási I; Papp G; Róna E; Benedek S; Fekete S
Rofo; 1988 Oct; 149(4):427-8. PubMed ID: 2845515
[TBL] [Abstract][Full Text] [Related]
7. [Combined bone marrow and skeletal scintigraphy in osseous and myelogenous diseases].
Hotze A; Löw A; Mahlstedt J; Wolf F
Rofo; 1984 Jun; 140(6):717-23. PubMed ID: 6234628
[TBL] [Abstract][Full Text] [Related]
8. [Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases].
Lumbroso J; Guermazi F; Hartmann O; Coornaert S; Rabarison Y; Lemerle J; Parmentier C
Bull Cancer; 1988; 75(1):97-106. PubMed ID: 3359060
[TBL] [Abstract][Full Text] [Related]
9. Tc-99m(V) DMSA imaging. A new approach to studying metastases from breast carcinoma.
Kashyap R; Babbar A; Sahai I; Prakash R; Soni NL; Chauhan UP
Clin Nucl Med; 1992 Feb; 17(2):119-22. PubMed ID: 1314148
[TBL] [Abstract][Full Text] [Related]
10. Fusion lymphoscintigraphy with a 24-hour Tc-99m MDP bone scan for sentinel lymph node detection and imaging.
Tatini VR; Dworkin HJ
Clin Nucl Med; 2001 Jan; 26(1):53. PubMed ID: 11139054
[TBL] [Abstract][Full Text] [Related]
11. Detection of bone metastases in patients with breast cancer.
Coombes RC; Dearnaley DP; Buckman R; Jones JM; Ormerod MG; Sloane JP; Powles TJ; Gazet JC; Ford HT; Neville AM
Invasion Metastasis; 1982; 2(3):177-84. PubMed ID: 6234254
[TBL] [Abstract][Full Text] [Related]
12. Negative bone scintigraphy with diffuse osteoblastic breast carcinoma metastases.
Brown B; Laorr A; Greenspan A; Stadalnik R
Clin Nucl Med; 1994 Mar; 19(3):194-6. PubMed ID: 8033466
[TBL] [Abstract][Full Text] [Related]
13. Bone scan and bone biopsy in the detection of skeletal metastases.
Ron IG; Striecker A; Lerman H; Bar-Am A; Frisch B
Oncol Rep; 1999; 6(1):185-8. PubMed ID: 9864425
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow biopsy and bone scan to detect skeletal metastases.
Mirza I; Cuello B; Ramachandran A; Johns W
Clin Nucl Med; 2001 Aug; 26(8):677-9. PubMed ID: 11452172
[TBL] [Abstract][Full Text] [Related]
15. Discordant findings of skeletal metastasis between tc 99M MDP bone scans and F18 FDG PET/CT imaging for advanced breast and lung cancers--two case reports and literature review.
Chen YW; Huang MY; Hsieh JS; Hou MF; Chou SH; Lin CL
Kaohsiung J Med Sci; 2007 Dec; 23(12):639-46. PubMed ID: 18192101
[TBL] [Abstract][Full Text] [Related]
16. [NMR tomography in plasmacytoma].
Linden A; Gückel C; Widder R; Jungehülsing M; Diehl V; Schicha H
Rofo; 1992 Jan; 156(1):83-8. PubMed ID: 1733480
[TBL] [Abstract][Full Text] [Related]
17. Colloid scintigraphy showing red bone marrow extension in patients with prostatic carcinoma.
Rudberg U; Udén R; Ahlbäck SO
Acta Radiol; 1992 Mar; 33(2):97-102. PubMed ID: 1562417
[TBL] [Abstract][Full Text] [Related]
18. The usefulness of bone-marrow scintigraphy in the detection of bone metastasis from prostatic cancer.
Otsuka N; Fukunaga M; Sone T; Yoneda M; Saito N; Tanaka H; Tomomitsu T; Yanagimoto S; Muranaka A; Morita R
Eur J Nucl Med; 1985; 11(8):319-22. PubMed ID: 4076240
[TBL] [Abstract][Full Text] [Related]
19. Increased uptake at sites of bone marrow biopsy mimicking bony metastases on Tc-99m MDP bone scintigraphy.
Lim ST; Sohn MH; Kwak JY; Yim CY
Clin Nucl Med; 2001 Apr; 26(4):365-6. PubMed ID: 11290911
[No Abstract] [Full Text] [Related]
20. Bone marrow immunoscintigraphy for the detection of skeletal metastases in patients with breast cancer.
Lacić M; Bokulić T; Lukac J; Kovacić K; Baum RP; Kusić Z
Nucl Med Commun; 1999 Feb; 20(2):135-43. PubMed ID: 10088162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
